Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
44.91
+3.17 (7.59%)
At close: Aug 13, 2025, 4:00 PM
45.10
+0.19 (0.42%)
After-hours: Aug 13, 2025, 7:42 PM EDT
Exact Sciences Employees
Exact Sciences had 7,000 employees as of December 31, 2024. The number of employees increased by 400 or 6.06% compared to the previous year.
Employees
7,000
Change (1Y)
400
Growth (1Y)
6.06%
Revenue / Employee
$419,993
Profits / Employee
-$143,603
Market Cap
8.50B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7,000 | 400 | 6.06% |
Dec 31, 2023 | 6,600 | 200 | 3.13% |
Dec 31, 2022 | 6,400 | -100 | -1.54% |
Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
Dec 31, 2020 | 5,000 | 890 | 21.65% |
Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
Dec 31, 2018 | 1,977 | 709 | 55.91% |
Dec 31, 2017 | 1,268 | 532 | 72.28% |
Dec 31, 2016 | 736 | 59 | 8.71% |
Dec 31, 2015 | 677 | 441 | 186.86% |
Dec 31, 2014 | 236 | 134 | 131.37% |
Dec 31, 2013 | 102 | 15 | 17.24% |
Dec 31, 2012 | 87 | 26 | 42.62% |
Dec 31, 2011 | 61 | 26 | 74.29% |
Dec 31, 2010 | 35 | 16 | 84.21% |
Dec 31, 2009 | 19 | 15 | 375.00% |
Dec 31, 2008 | 4 | -10 | -71.43% |
Dec 31, 2007 | 14 | -8 | -36.36% |
Dec 31, 2006 | 22 | -27 | -55.10% |
Dec 31, 2005 | 49 | -22 | -30.99% |
Dec 31, 2004 | 71 | -11 | -13.41% |
Dec 31, 2003 | 82 | 7 | 9.33% |
Dec 31, 2002 | 75 | 7 | 10.29% |
Dec 31, 2001 | 68 | 24 | 54.55% |
Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EXAS News
- 2 days ago - Top 3 Health Care Stocks That Are Preparing To Pump This Month - Benzinga
- 6 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 6 days ago - Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst - Benzinga
- 7 days ago - Exact Sciences Corporation (EXAS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Exact Sciences Announces Second Quarter 2025 Results - Business Wire
- 7 days ago - Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests - Business Wire
- 13 days ago - Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test - Business Wire
- 4 weeks ago - Exact Sciences Schedules Second Quarter 2025 Earnings Call - Business Wire